Substituted benzamides as anti-inflammatory agents
申请人:Riker Laboratories, Inc.
公开号:US04128664A1
公开(公告)日:1978-12-05
Compounds in which 2,6-di(t-butyl)phenol is substituted in the 4 position by an N-substituted carboxamido group have valuable pharmacological activity as anti-inflammatory agents.
Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy
申请人:ELI LILLY AND COMPANY
公开号:EP0476846A2
公开(公告)日:1992-03-25
Provided are methods of treating inflammation, arthritis and muscular dystrophy and preventing ischemia-induced cell damage employing certain phenol and benzamide compounds.
The present invention provides a method for treating inflammatory bowel disease in mammals utilizing certain phenol and benzamide compounds.
本发明提供了一种利用某些苯酚和苯甲酰胺化合物治疗哺乳动物炎症性肠病的方法。
Composition containing certain phenol and benzamide for the treatment of type I diabetes
申请人:UNIVERSITY OF COLORADO FOUNDATION, INC.
公开号:EP0500336A1
公开(公告)日:1992-08-26
Provided is a method for treating Type I diabetes in mammals, and novel formulations suitable therefor, employing certain phenol and benzamide compounds.
本发明提供了一种利用某些苯酚和苯甲酰胺化合物治疗哺乳动物 I 型糖尿病的方法,以及适用于该方法的新型制剂。
Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy
申请人:ELI LILLY AND COMPANY
公开号:EP0680755A1
公开(公告)日:1995-11-08
Provided are methods of treating inflammation, arthritis and muscular dystrophy and preventing ischemia-induced cell damage employing certain phenol and benzamide compounds.